Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Information Technology RFPsInformation Technology and Software Development Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More IT services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›?Mitigating Proliferation Risks Posed by Artificial…

U.S. Bureau of Arms Control and Nonproliferation·United States of America

?Mitigating Proliferation Risks Posed by Artificial Intelligence Enabled Molecular Models and Leveraging Nonproliferation Opportunities?

Closes 7/21/2026$2M – $4MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The U.S. Department of State's Bureau of Arms Control and Nonproliferation is seeking proposals for a project that aims to mitigate the proliferation risks posed by artificial intelligence (AI) enabled molecular models. The project will focus on identifying potential vulnerabilities and developing safeguards to counter the misuse of AI models in the chemical and biological fields. The successful applicant will be expected to develop and conduct technical evaluations and risk assessments, test established and develop new safeguards, and develop tools and methodologies to detect and counter illicit chemical and biological proliferation activities. Some key objectives of this project include: • Identifying key foreign stakeholders involved in AI enabled molecular design and production • Developing and conducting technical evaluations and risk assessments of training data sets, model architectures, computing systems, and related infrastructure used to develop AI molecular models • Testing established and developing new safeguards, mitigation measures, and best practices to secure sensitive data sets, computing systems, infrastructure, and molecular models • Developing tools, methodologies, and other resources that leverage beneficial applications of AI to detect and counter illicit chemical and biological material acquisition, development, diversion, proliferation, weaponization, and use activities The project is expected to have a duration of 24 months, and the estimated funding for this project is $4,000,000.

Attached files

Contact

[email protected]

771-204-0446

Key dates

Opened
5/21/2026
Closes
7/21/2026
Duration
24 months

Last updated

Details

Type
Grants Notice
Industry
Information Technology and Software Development
NAICS
541710
Solicitation №
DFOP0018449

Budget estimate

$2,000,000 – $4,000,000

The estimated budget for this opportunity is $4,000,000. This estimate is based on the information provided in the document, which states that the available funding for this project is $4,000,000. The actual budget may vary depending on the specific proposal and the needs of the project. The factors that may influence the likely payment range include the scope of work, the complexity of the project, and the qualifications and experience of the applicant.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Office of Science·United States of America

Top match · 73%

The Genesis Mission: Transforming Science and Energy with AI

Closes 12/17/2026Opened 3/17/2026

U.S. National Institutes of Health·United States of America

72% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. Department Of Defense·Maryland

72% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 10/18/2024

U.S. Department Of Defense·Maryland

71% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

70% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

70% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

69% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. Department Of Defense·Virginia

69% match

Atomically Precise Molecules (APM)

Closes 12/18/2026Opened 10/8/2026

U.S. National Science Foundation·United States of America

69% match

Science of Learning and Augmented Intelligence (SL)

Closes 9/1/2033Opened 9/19/2019

U.S. Department Of Defense·Maryland

69% match

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Closes 5/1/2036Opened 4/23/2026

U.S. Department Of Defense·Maryland

69% match

BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

Closes 12/31/2030Opened 3/24/2026

U.S. Department Of Energy·Ohio

69% match

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

Closes 12/17/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

69% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

68% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. Department Of Homeland Security·District of Columbia

68% match

DHS BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT (R&D) COUNTERING WEAPONS OF MASS DESTRUCTION (CWMD)

Closes 5/6/2029Opened 5/7/2024

U.S. Department Of Energy·Ohio

68% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. Department Of Defense·United States of America

68% match

Non-Optical Methods for High Speed Protein Control

Closes 12/31/2026Opened 7/21/2026

U.S. National Institutes of Health·United States of America

68% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

68% match

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

68% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. Department Of Defense·Virginia

68% match

FY25-29 STRATEGIC TRENDS RESEARCH INITIATIVE BROAD AGENCY ANNOUNCEMENT

Closes 7/31/2029Opened 8/2/2024

U.S. Food and Drug Administration·United States of America

68% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. National Institutes of Health·United States of America

68% match

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Closes 2/9/2027Opened 8/20/2026

U.S. Department Of Defense·Maryland

68% match

BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS

Closes 8/20/2029Opened 3/11/2025